lamotrigine + vofopitant

Lamotrigine + vofopitant is a combination of two **small molecule drugs**, likely considered for synergistic therapy. **Lamotrigine** is a phenyltriazine anticonvulsant primarily used for epilepsy and as a mood stabilizer in bipolar disorder. Its mechanism involves inhibition of voltage-sensitive sodium channels, stabilizing neuronal membranes and thereby inhibiting release of excitatory neurotransmitters (such as glutamate)[4]. **Vofopitant** is an investigational neurokinin-1 (NK1) receptor antagonist, developed primarily for conditions involving stress or emesis. The rationale behind combining these agents would likely relate to targeting both seizure or mood stability (via lamotrigine) and stress-related or emetic components (via vofopitant). Evidence for the combination as a clinical entity is extremely limited or absent in public data; combination use may be hypothetical or early-phase research.

Other names

lamotriginevofopitant